371 related articles for article (PubMed ID: 22570492)
1. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria.
Clausen TM; Christoffersen S; Dahlbäck M; Langkilde AE; Jensen KE; Resende M; Agerbæk MØ; Andersen D; Berisha B; Ditlev SB; Pinto VV; Nielsen MA; Theander TG; Larsen S; Salanti A
J Biol Chem; 2012 Jul; 287(28):23332-45. PubMed ID: 22570492
[TBL] [Abstract][Full Text] [Related]
2. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains.
Dahlbäck M; Jørgensen LM; Nielsen MA; Clausen TM; Ditlev SB; Resende M; Pinto VV; Arnot DE; Theander TG; Salanti A
J Biol Chem; 2011 May; 286(18):15908-17. PubMed ID: 21398524
[TBL] [Abstract][Full Text] [Related]
3. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
[TBL] [Abstract][Full Text] [Related]
4. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites.
Resende M; Ditlev SB; Nielsen MA; Bodevin S; Bruun S; Pinto VV; Clausen H; Turner L; Theander TG; Salanti A; Dahlbäck M
Int J Parasitol; 2009 Sep; 39(11):1195-204. PubMed ID: 19324047
[TBL] [Abstract][Full Text] [Related]
5. VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta.
Rovira-Vallbona E; Monteiro I; Bardají A; Serra-Casas E; Neafsey DE; Quelhas D; Valim C; Alonso P; Dobaño C; Ordi J; Menéndez C; Mayor A
PLoS One; 2013; 8(7):e69753. PubMed ID: 23936092
[TBL] [Abstract][Full Text] [Related]
6. Designing a VAR2CSA-based vaccine to prevent placental malaria.
Fried M; Duffy PE
Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA.
Ma R; Lian T; Huang R; Renn JP; Petersen JD; Zimmerberg J; Duffy PE; Tolia NH
Nat Microbiol; 2021 Mar; 6(3):380-391. PubMed ID: 33452495
[TBL] [Abstract][Full Text] [Related]
8. Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA.
Resende M; Nielsen MA; Dahlbäck M; Ditlev SB; Andersen P; Sander AF; Ndam NT; Theander TG; Salanti A
Malar J; 2008 Jun; 7():104. PubMed ID: 18534039
[TBL] [Abstract][Full Text] [Related]
9. Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions.
Fernandez P; Petres S; Mécheri S; Gysin J; Scherf A
PLoS One; 2010 Sep; 5(9):e12558. PubMed ID: 20838433
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into chondroitin sulphate A binding Duffy-binding-like domains from Plasmodium falciparum: implications for intervention strategies against placental malaria.
Gill J; Chitnis CE; Sharma A
Malar J; 2009 Apr; 8():67. PubMed ID: 19374733
[TBL] [Abstract][Full Text] [Related]
11. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies.
Khunrae P; Dahlbäck M; Nielsen MA; Andersen G; Ditlev SB; Resende M; Pinto VV; Theander TG; Higgins MK; Salanti A
J Mol Biol; 2010 Apr; 397(3):826-34. PubMed ID: 20109466
[TBL] [Abstract][Full Text] [Related]
12. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
[TBL] [Abstract][Full Text] [Related]
14. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA.
Srivastava A; Gangnard S; Round A; Dechavanne S; Juillerat A; Raynal B; Faure G; Baron B; Ramboarina S; Singh SK; Belrhali H; England P; Lewit-Bentley A; Scherf A; Bentley GA; Gamain B
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):4884-9. PubMed ID: 20194779
[TBL] [Abstract][Full Text] [Related]
15. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
[TBL] [Abstract][Full Text] [Related]
17. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
18. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
[TBL] [Abstract][Full Text] [Related]
19. Characterization of VAR2CSA-deficient Plasmodium falciparum-infected erythrocytes selected for adhesion to the BeWo placental cell line.
Yosaatmadja F; Andrews KT; Duffy MF; Brown GV; Beeson JG; Rogerson SJ
Malar J; 2008 Mar; 7():51. PubMed ID: 18364051
[TBL] [Abstract][Full Text] [Related]
20. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
Elife; 2022 Feb; 11():. PubMed ID: 35103596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
